Systematic review of patients' and healthcare professionals' views on patient-initiated follow-up in treated cancer patients.
Janine DretzkeAva LorencAda AdrianoClare HerdHisham MehannaPaul NankivellDavid J Moorenull nullPublished in: Cancer medicine (2023)
PIFU is viewed mostly positively by women treated for breast or endometrial cancer, and by HCPs, but further evidence is needed from a wider range of cancers, men, and more representative samples. A protocol was registered with PROSPERO (CRD42020181412).
Keyphrases
- endometrial cancer
- systematic review
- newly diagnosed
- end stage renal disease
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- prognostic factors
- meta analyses
- polycystic ovary syndrome
- case report
- type diabetes
- patient reported outcomes
- metabolic syndrome
- middle aged
- skeletal muscle
- cervical cancer screening